Surgical management for non-functional pancreatic neuroendocrine neoplasms with synchronous liver metastasis: A consensus from the Chinese Study Group for Neuroendocrine Tumors (CSNET)

被引：40

作者：

Jin, Kaizhou ^{[1
,2
,3
]}

Xu, Jin ^{[1
,2
,3
]}

Chen, Jie ^{[4
]}

Chen, Minhu ^{[4
]}

Chen, Rufu ^{[5
]}

Chen, Ye ^{[6
]}

Chen, Zhiyu ^{[7
]}

Cheng, Bin ^{[8
]}

Chi, Yihebali ^{[9
]}

Feng, Shi-Ting ^{[10
]}

Fu, Deliang ^{[11
]}

Hou, Baohua ^{[12
]}

Huang, Dan ^{[13
]}

Huang, Heguang ^{[14
]}

Huang, Qiang ^{[15
]}

Li, Jie ^{[16
,17
]}

Li, Ying ^{[18
]}

Liang, Houjie ^{[19
]}

Lin, Rong ^{[20
]}

Liu, An'an ^{[21
]}

Liu, Jixi ^{[22
]}

Liu, Xubao ^{[23
]}

Lu, Ming ^{[16
,17
]}

Lu, Jie ^{[24
]}

Mai, Gang ^{[25
]}

Ni, Quanxing ^{[1
,2
,3
]}

Qiu, Meng ^{[26
]}

Shao, Chenghao ^{[21
]}

Shen, Baiyong ^{[27
]}

Sheng, Weiqi ^{[13
]}

Sun, Jian ^{[5
]}

Tan, Chunlu ^{[23
]}

Tan, Huangying ^{[28
,29
]}

Tang, Qiyun

Tang, Yingmei ^{[30
]}

Tian, Xiaodong ^{[31
]}

Tong, Danian ^{[32
]}

Wang, Xiaohong ^{[33
]}

Wang, Jian ^{[34
]}

Wang, Jie ^{[35
]}

Wang, Wei ^{[36
,37
]}

Wang, Yu ^{[38
]}

Wu, Zheng ^{[39
]}

Xue, Ling ^{[40
]}

Yan, Qiang ^{[41
]}

Yang, Ning ^{[42
]}

Yang, Yinmo ^{[31
]}

Yang, Zhiying ^{[43
]}

Yin, Xiaoyi ^{[44
]}

机构：

[1] Fudan Univ, Shanghai Canc Ctr, Dept Pancreat Surg, 270 Dong An Rd, Shanghai 200032, Peoples R China

[2] Fudan Univ, Pancreat Canc Inst, Shanghai, Peoples R China

[3] Fudan Univ, Shanghai Med Coll, Dept Oncol, Shanghai, Peoples R China

[4] Sun Yat Sen Univ, Affiliated Hosp 1, Dept Gastroenterol, Guangzhou, Guangdong, Peoples R China

[5] Sun Yat Sen Univ, Sun Yat Sen Mem Hosp, Dept Biliary Pancreat Surg, Guangzhou, Guangdong, Peoples R China

[6] Southern Med Univ, Nanfang Hosp, Dept Gastroenterol, Guangzhou, Guangdong, Peoples R China

[7] Fudan Univ, Shanghai Canc Ctr, Dept Med Oncol, Shanghai, Peoples R China

[8] Huazhong Univ Sci & Technol, Tongji Hosp, Dept Gastroenterol, Tongji Med Coll, Wuhan, Hubei, Peoples R China

[9] Chinese Acad Med Sci, Canc Inst & Hosp, Dept Med Oncol, Beijing, Peoples R China

[10] Sun Yat Sen Univ, Affiliated Hosp 1, Dept Radiol, Guangzhou, Guangdong, Peoples R China

[11] Fudan Univ, Huashan Hosp, Dept Pancreat Surg, Shanghai, Peoples R China

[12] Guangdong Gen Hosp, Dept Gen Surg, Guangzhou, Guangdong, Peoples R China

[13] Fudan Univ, Shanghai Canc Ctr, Dept Pathol, Shanghai, Peoples R China

[14] Fujian Med Univ, Dept Gen Surg, Union Hosp, Fuzhou, Fujian, Peoples R China

[15] Anhui Prov Hosp, Dept Gen Surg, Hefei, Anhui, Peoples R China

[16] Peking Univ, Canc Hosp, Dept Gastrointestinal Oncol, Beijing, Peoples R China

[17] Beijing Canc Hosp, Beijing, Peoples R China

[18] Peking Univ, Canc Hosp, Dept Radiol, Beijing, Peoples R China

[19] Third Mil Med Univ, Southwest Hosp, Dept Oncol, Chongqing, Peoples R China

[20] Huazhong Univ Sci & Technol, Wuhan Union Hosp, Tongji Med Coll, Dept Gastroenterol, Wuhan, Hubei, Peoples R China

[21] Second Mil Med Univ, Changzheng Hosp, Dept Gen Surg, Shanghai, Peoples R China

[22] China Japan Friendship Hosp, Dept Gastroenterol, Beijing, Peoples R China

[23] Sichuan Univ, West China Hosp, Dept Hepatobiliopancreat Surg, Chengdu, Sichuan, Peoples R China

[24] China Japan Friendship Hosp, Dept Pathol, Beijing, Peoples R China

[25] Peoples Hosp Deyang, Dept Hepatobiliopancreat Surg, Chengdu, Sichuan, Peoples R China

[26] Sichuan Univ, West China Hosp, Ctr Canc, Dept Abdominal Oncol, Chengdu, Sichuan, Peoples R China

[27] Shanghai Jiao Tong Univ, Ruijin Hosp, Dept Gen Surg, Sch Med, Shanghai, Peoples R China

[28] China Japan Friendship Hosp, Dept Integrat Oncol, Beijing, Peoples R China

[29] Jiangsu Peoples Hosp, Dept Gastroenterol, Nanjing, Jiangsu, Peoples R China

[30] Kunming Med Univ, Yunnan Res Ctr Liver Dis, Dept Gastroenterol, Affliated Hosp 2, Kunming, Yunnan, Peoples R China

[31] Peking Univ, Dept Gen Surg, Hosp 1, Beijing, Peoples R China

[32] Shanghai Jiao Tong Univ, Affiliated Peoples Hosp 6, Dept Surg, Shanghai, Peoples R China

[33] Fudan Univ, Shanghai Canc Ctr, Dept Radiol, Shanghai, Peoples R China

[34] Shanghai Jiao Tong Univ, Sch Med, Renji Hosp, Dept Biliary Pancreat Surg, Shanghai, Peoples R China

[35] Sun Yat Sen Univ, Sun Yat Sen Mem Hosp, Dept Hepatobiliary Surg, Guangzhou, Guangdong, Peoples R China

[36] Fudan Univ, Huadong Hosp, Dept Surg, Shanghai, Peoples R China

[37] Sun Yat Sen Univ, Dept Gastr & Pancreat Surg, Ctr Canc, Guangzhou, Guangdong, Peoples R China

[38] Sun Yat Sen Univ, Affiliated Hosp 1, Dept Intervent Oncol, Guangzhou, Guangdong, Peoples R China

[39] Xi An Jiao Tong Univ, Affiliated Hosp 1, Dept Hepatobiliary Surg, Xian, Shaanxi, Peoples R China

[40] Sun Yat Sen Univ, Affiliated Hosp 1, Dept Pathol, Guangzhou, Guangdong, Peoples R China

[41] Huzhou Cent Hosp, Dept Hepatobiliopancreat Surg, Huzhou, Zhejiang, Peoples R China

[42] Eastern Hepatobiliary Surg Hosp, Hepatobiliary Surg Dept 5, Shanghai, Peoples R China

[43] China Japan Friendship Hosp, Dept Hepatobiliary Surg, Beijing, Peoples R China

[44] Sun Yat Sen Univ, Affiliated Hosp 1, Dept Biliary Pancreat Surg, Guangzhou, Guangdong, Peoples R China

[45] Peking Univ, Hosp 3, Dept Gen Surg, Beijing, Peoples R China

[46] Cent S Univ, Xiangya Hosp, Dept Oncol, Changsha, Hunan, Peoples R China

[47] Zhejiang Prov Peoples Hosp, Dept Gastrointestinal & Pancreat Surg, Hangzhou, Zhejiang, Peoples R China

来源：

INTERNATIONAL JOURNAL OF ONCOLOGY | 2016年 / 49卷 / 05期

关键词：

surgical managemerit; non-functional pancreatic neuroendocrine neoplasms; synchronous liver metastasis; consensus; Chinese Study Group for Neuroendocrine Tumors (CSNET); FINE-NEEDLE-ASPIRATION; LONG-TERM SURVIVAL; ENDOCRINE TUMORS; HIGH-GRADE; CARCINOID-TUMORS; UNKNOWN PRIMARY; ENDOSCOPIC ULTRASONOGRAPHY; PROGNOSTIC-FACTORS; PATIENT SELECTION; LABELING INDEX;

D O I：

10.3892/ijo.2016.3711

中图分类号：

R73 [肿瘤学];

学科分类号：

100214 ;

摘要：

Pancreatic neuroendocrine neoplasms (p-NENs) are slowly growing tumors with frequent liver metastasis. There is a variety of approaches to treat non-functional p-NENs with synchronous liver metastasis (LM) which complicates the determination of optimal treatment. Based on updated literature review, we discussed the treatment strategy determinants for p-NEN with LM. According to the resectability of primary tumor, the WHO 2010 grade classification and the radiological type of liver metastasis, the CSNET group reached agreements on a number of issues, including the following. Prior to treatment, biopsy is required to confirm pathology. Liver biopsy is important for more accurate grading of tumor and percutaneous core needle biopsy is more available than EUS-FNA. In patients with unresectable primary, surgical resection for liver-metastatic lesions should be avoided. Curative surgery is recommended for G1/G2 p-NET with type I LM and R1 resection also seems to improve overall survival rate. Cytoreductive surgery is recommended for G1G2 p-NET with type II LM in select patients, and should meet stated requirements. Surgical resection for G1G2 p-NET with type III LM and p-NEC with LM should be avoided, and insufficient evidence exists to guide the surgical treatment of G3 p-NET with LM. Liver transplantation may be an option in highly select patients. In addition, the optimal time for surgical approach is still required for more evidence.

引用

页码：1991 / 2000

页数：10

共 33 条

[31] ENETS Consensus Guidelines for the Management of Patients with Liver and Other Distant Metastases from Neuroendocrine Neoplasms of Foregut, Midgut, Hindgut, and Unknown Primary
Pavel, Marianne
Baudin, Eric
Couvelard, Anne
Krenning, Eric
Oberg, Kjell
Steinmueller, Thomas
Anlauf, Martin
Wiedenmann, Bertram
Salazar, Ramon
NEUROENDOCRINOLOGY, 2012, 95 (02) : 157 - 176
[32] A comprehensive validation of the novel 8th edition of American Joint Committee on Cancer staging manual for the long-term survivals of patients with non-functional pancreatic neuroendocrine neoplasms
Yang, Min
Zeng, Lin
Yao, Wen-Qing
Ke, Neng-wen
Tan, Chun-lu
Tian, Bo-le
Liu, Xu-bao
Xiang, Bo
Zhang, Yi
MEDICINE, 2020, 99 (46) : E22291
[33] Natural history of gastro-entero-pancreatic and thoracic neuroendocrine tumors. Data from a large prospective and retrospective Italian Epidemiological study: THE NET MANAGEMENT STUDY
Faggiano, A.
Ferolla, P.
Grimaldi, F.
Campana, D.
Manzoni, M.
Davi, M. V.
Bianchi, A.
Valcavi, R.
Papini, E.
Giuffrida, D.
Ferone, D.
Fanciulli, G.
Arnaldi, G.
Franchi, G. M.
Francia, G.
Fasola, G.
Crino, L.
Pontecorvi, A.
Tomassetti, P.
Colao, A.
JOURNAL OF ENDOCRINOLOGICAL INVESTIGATION, 2012, 35 (09) : 817 - 823

← 1 2 3 4 →